Navigation Links
New Research Uncovers Elusive Target of Antifungal Agent
Date:6/13/2010

A research team in Japan has uncovered the mechanism underlying the antifungal activity of theonellamide (TNM), a bioactive compound found in a species of marine sponge. The finding, reported in Nature Chemical Biology, provides new insights toward the development of antifungal drugs, with broader applications to drug analysis in areas such as cancer research.

(PRWeb UK) June 13, 2010 -- A research team in Japan has uncovered the mechanism underlying the antifungal activity of theonellamide (TNM), a bioactive compound found in a species of marine sponge. The finding, reported in Nature Chemical Biology, provides new insights toward the development of antifungal drugs, with broader applications to drug analysis in areas such as cancer research.

Designing drugs that target fungal cells poses serious challenges due to their similarity to human cells at the molecular level. To avoid damaging human cells, such drugs exploit differences between mammalian and fungal cells, both of which, unlike bacteria, are in the same family of eukaryotes. The difficulty of this task results in toxic side effects and a shortage of effective antifungal agents.

The research team, headed by scientists at the RIKEN Advanced Science Institute, set out to tackle this problem by investigating the antifungal activity of theonellamides (TNMs), bicyclic peptides found in the marine sponge Theonella, on the fission yeast. Combining chemical-genetic profiling and biochemical and cellular analysis, they deduced that TNMs bind to a class of lipid molecules (3?-hydroxysterols) in the cell membrane to induce overproduction of 1,3-?-D-glucan, a component of the cell wall.

Antifungal activity in TNMs, the researchers showed, is thus different from other antifungals, which cause damage by impairing wall synthesis. Instead, TNMs damage fungal cells by abnormally promoting such synthesis, targeting not proteins as previously thought, but a class of lipids, including ergosterol. TNMs thus represent an entirely new class of sterol-binding molecules, offering a new direction in the development of antifungal agents and a powerful tool for drug analysis.

For more information, please contact:

Dr. Minoru Yoshida
Chemical Genomics Research Group
RIKEN Advanced Science Institute
Tel: +81-(0)48-467-9516 / Fax: +81-(0)48-467-4676

Ms. Tomoko Ikawa (PI officer)
Global Relations Office
RIKEN
Tel: +81-(0)48-462-1225 / Fax: +81-(0)48-462-4715

# # #

Read the full story at http://www.prweb.com/releases/2010/06/prweb4131144.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. New research identifies modifiable risk factors for heart disease
2. Nuvo Research announces early redemption of 5% convertible debentures
3. Researcher to track spread of disease, malware and power outages
4. UCSF Researchers Identify Regulator of Human Sperm Cells
5. Octapharma Accepting Applications for Research Grants Through March 31
6. Valentine Tailgate Party for the Girls with Festive Ideas from Beauty Research
7. New Research Shows Genes of Pregnant Women and Their Fetuses Can Increase the Risk of Preterm Labor
8. University of Maryland chemist receives Astellas Award for blindness prevention research
9. Developing a cyberinfrastructure for comparative effectiveness in cancer research
10. Women should be allowed to eat, drink during labor: Queens University researcher
11. Parkinsons disease research uncovers social barrier
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Research Uncovers Elusive Target of Antifungal Agent
(Date:7/23/2017)... ... ... “Squiggy’s Outdoor Adventure”: a turtle’s backyard adventure that teaches the importance of ... Christian, a wife and mother to three amazing, and supportive, children. Paula lives ... God. She loves to tell stories to her children, play board games, bake, ...
(Date:7/22/2017)... ... July 22, 2017 , ... The arthroscopic superior ... the opportunity to return to sports and jobs that require heavy physical work, ... Medicine’s Annual Meeting in Toronto, Ontario, Canada. , “We studied 100 ...
(Date:7/21/2017)... Augusta, GA (PRWEB) , ... July 21, 2017 , ... ... is teaming up with the Epilepsy Foundation in a community wide charity event with ... region. , Delaney Sunde, a young local woman who lives with epilepsy, recently launched ...
(Date:7/21/2017)... ... , ... Fresh Wave® IAQ today announced the launch of its innovative ... at the APPA 2017 Annual Conference and Exhibition in Booth #414. , ... the use of harsh chemicals, Fresh Wave IAQ Smoke Away Air & Fabric Liquid ...
(Date:7/21/2017)... ... ... Margarian Law Firm has filed a class action lawsuit against Dr. Pepper ... Dr. Pepper produces the “Canada Dry” brand of ginger ale products. In Gegham Margaryan ... claims on its bottle that it is made from real ginger. , When consumers ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... 10, 2017  BDI Group subsidiary Pathway Purchasing ... services organization serving specialty pharmacies, home infusion companies ... four significant, value-added member programs designed to help ... reimbursement and improve access and affordability for patients ... Pathway has ...
(Date:7/6/2017)... 6, 2017 ThriveRx, the nutrition division of Diplomat Specialty Infusion ... thrive on nutrition support. To celebrate its anniversary, ThriveRx recently ... a fresh new look with improved organization to create the best user ... ... "We,ve made several ...
(Date:7/5/2017)... company of over 2,000 employees and a leader in environmental and life science ... their position as the top American owned and operated environmental testing firm in ... ... ... , enhances Pace Analytical,s capability as an innovative full service provider in ...
Breaking Medicine Technology: